Shares of Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) hit a new 52-week low during mid-day trading on Monday . The company traded as low as $29.31 and last traded at $30.15, with a volume of ...

Legend Biotech's Carvykti shows strong efficacy in multiple myeloma as U.S.-based manufacturing shields it from tariffs and global regulatory risks.

According to Benzinga Pro, Legend Biotech's peer group average for short interest as a percentage of float is 10.75%, which ...

Learn more about whether Legend Biotech Corporation or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Day One Biopharmaceuticals has higher earnings, but lower revenue than Legend Biotech. Legend Biotech is trading at a lower price-to-earnings ratio than Day One Biopharmaceuticals, indicating that ...

Analysts' ratings for Legend Biotech (NASDAQ:LEGN) over the last quarter vary from bullish to bearish, as provided by 5 analysts. The following table encapsulates their recent ratings, offering a ...

Learn more about whether Alvotech or Legend Biotech Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

5 analysts have shared their evaluations of Legend Biotech (NASDAQ:LEGN) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below summarizes their ...

In a report released on April 3, Leonid Timashev from RBC Capital maintained a Buy rating on Legend Biotech (LEGN – Research Report), with a ...

During the webcast and conference call, senior leaders will provide an overview of Legend Biotech’s quarter and fiscal year performance. Investors and other interested parties may join the live ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to take a look at where Legend Biotech Corporation (NASDAQ:LEGN) stands ...